SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437786-17-000034
Filing Date
2017-08-02
Accepted
2017-08-02 16:37:15
Documents
57
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q imdz630201710-q.htm 10-Q 943929
2 EXHIBIT 31.1 ex311imdz2017q2.htm EX-31.1 8013
3 EXHIBIT 31.2 ex312imdz2017q2.htm EX-31.2 8115
4 EXHIBIT 32.1 ex321imdz2017q2.htm EX-32.1 4867
5 EXHIBIT 32.2 ex322imdz2017q2.htm EX-32.2 5119
  Complete submission text file 0001437786-17-000034.txt   4415767

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT imdz-20170630.xml EX-101.INS 807584
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imdz-20170630.xsd EX-101.SCH 36795
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imdz-20170630_cal.xml EX-101.CAL 54358
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imdz-20170630_def.xml EX-101.DEF 163974
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imdz-20170630_lab.xml EX-101.LAB 496558
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imdz-20170630_pre.xml EX-101.PRE 280561
Mailing Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102 (206) 682-0645
Immune Design Corp. (Filer) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36561 | Film No.: 171000432
SIC: 2834 Pharmaceutical Preparations